Skip to main content

HFpEF

Decoding the Future of Heart Failure — Emerging Strategies in HF with EF ≥40%: Key Takeaways from 2024
  • 1.00 EBAC

Learning objectives

  • Summarise the long-term burden and current unmet needs for patients with HF and EF ≥40%
  • Recall data on new therapies being evaluated in the HFmr/pEF population, including data from the AHA 2024 annual congress
  • Describe how non-steroidal MRAs differ in their mechanism of action and elicit their benefits in HF
See more
Medical Options for Advanced HFpEF/HFmrEF Patients: An Expert-Guided Virtual Ward Round
  • 1.00 EBAC

Learning objectives

  • Describe the current limitations of HFmrEF/HFpEF GDMT in advanced patients
  • Select appropriate patients for advanced medical therapy
  • Recall recent trial data for novel therapeutic approaches
  • Use expert guidance to develop an evidence-based approach to managing advanced HFmrEF/HFpEF
See more